Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

CEC levels may be a useful marker for predicting prostate cancer progression.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Provenge extends prostate cancer survival by about 4 months.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Gene variation affects prostate issues and hair loss.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Minoxidil can reduce functions related to androgen receptors.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

CT scans can find serious prostate cancer even when PSA levels are low.